Details for 2021714345

Up to date per 01.04.2026

Actions

Title / Product Name

METHODEN BEINHALTEND NEUTROPHILE ELASTASE INHIBITOR ALVELESTAT ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNG AUFGRUND VON ALPHA-1 ANTITRYPSIN MANGEL

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021714345

EP Publication Number

4106757

E-Number

1601765

Language

PCT Number

GB21050653

Publication Date

28.12.2022 A

23.08.2023 B1

Registration Date

23.08.2023

AT Publication Date

15.09.2023

Application Date

16.03.2021

Registration Number

Priorities

16.04.2020

202005519

16.04.2020

202005520

04.08.2020

202062706195 P

IPC

A61K 31/444 20060101AFI20211022BHEP

Maximum Duration of Protection

16.03.2041

Owner

Mereo Biopharma 4 Limited1 Cavendish Place London Greater London W1G 0QFGB

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

PARKIN, Jacqueline1 Cavendish Place London W1G 0QFGB

Information about Fees